期刊
CELL STEM CELL
卷 5, 期 5, 页码 491-503出版社
CELL PRESS
DOI: 10.1016/j.stem.2009.09.012
关键词
-
资金
- Harvard Stem Cell Institute
- NIH [R01 HD046732-01A1, GM065400]
- NYSCF
- Howard Hughes Medical Institute
- Sankyo Foundation of Life Science
The combined activity of three transcription factors can reprogram adult cells into induced pluripotent stem cells (iPSCs). However, the transgenic methods used for delivering reprogramming factors have raised concerns regarding the future utility of the resulting stem cells. These uncertainties could be overcome if each transgenic factor were replaced with a small molecule that either directly activated its expression from the somatic genome or in some way compensated for its activity. To this end, we have used high-content chemical screening to identify small molecules that can replace Sox2 in reprogramming. We show that one of these molecules functions in reprogramming by inhibiting Tgf-beta signaling in a stable and trapped intermediate cell type that forms during the process. We find that this inhibition promotes the completion of reprogramming through induction of the transcription factor Nanog.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据